Corporate Directory

Directors

Malcolm McComas – Chairman

Gary Phillips - Chief Executive Officer

Simon Buckingham – Non Executive Director

Will Delaat – Non Executive Director

Kathleen Metters - Non Executive Director 

Company Secretary and Chief Financial Officer

David McGarvey
E| 
david.mcgarvey@pharmaxis.com.au

Investor relations enquiries

David McGarvey
E | 
david.mcgarvey@pharmaxis.com.au

Media enquiries

Felicity Moffatt
E| 
felicity.moffatt@pharmaxis.com.au

Partnership and collaboration enquiries

Gary Phillips 
E | gary.phillips@pharmaxis.com.au

Registered office

20 Rodborough Road
Frenchs Forest NSW 2086
Australia
Telephone: +61 2 9454 7200
Fax: +61 2 9451 3622
Email: info@pharmaxis.com.au
Website: www.pharmaxis.com.au

Securities exchange listings

Pharmaxis shares are listed on the Australian Stock Exchange (Code: PXS)
Pharmaxis American Depositary Receipts are traded on the US over-the-counter market (Code: PXSLY)

Legal advisors

PFM Legal Pty Ltd
Level 7,
257 Clarence Street,
Sydney NSW 2000
Australia

Auditor

PricewaterhouseCoopers
Darling Park Tower 2
201 Sussex Street
Sydney NSW 2000
Australia

Banks

Westpac Banking Corporation

HSBC

Share registry

Computershare Investor Services Pty Ltd
Level 3, 60 Carrington Street
Sydney NSW 2000
Australia
Telephone: 1300 855 080
                  +61 (03) 9415 4000
Website: http://www.computershare.com.au

Shareholders can access information and services relevant to their holding from the Pharmaxis website under Investors /Shareholder Services

American depositary receipts

BNY Mellon Shareowner Services
P.O. Box 30170

College Station, TX 77842-3170

Telephone: 1-888-BNY-ADRS (1-888-269-2377)

(toll free number for domestic callers)

International: +1 201 680 6825